Untreated depression and non-medical use of prescription pain relievers: findings from the National Survey on Drug Use and Health 2008-2014

References

• Hughes A, Williams MR, Lipari RN, et al. Prescription drug use and misuse in the United States: results from the 2015 National survey on drug use and health. NSDUH data review; 2016. [cited 2018 Jul 23]. Available from: https://www.samhsa.gov/data/sites/default/files/NSDUH-FFR2-2015/NSDUH-FFR2-2015.htm
   Google Scholar
• Novak SP, Håkansson A, Martinez-Raga J, et al. Nonmedical prescription opioid use and DSM-5 nonmedical prescription opioid use disorder in the United States. J Clin Psychiatry. 2016;16:772–780.
   Google Scholar
• Saha TD, Kerridge BT, Goldstein RB, et al. Nonmedical prescription opioid use and DSM-5 nonmedical prescription opioid use disorder in the United States. J Clin Psychiatry. 2016;77:772–780.
   PubMed Web of Science ®Google Scholar
• Compton WM, Jones CM, Baldwin GT, et al. Relationship between nonmedical prescription-opioid use and heroin use. N Engl J Med. 2016;374:154–163.
   PubMed Web of Science ®Google Scholar
• Drazdowski TK. A systematic review of the motivations for the non-medical use of prescription drugs in young adults. Drug Alcohol Depend. 2016;162:3–25.
   PubMed Web of Science ®Google Scholar
• McCabe SE, Teter CJ, Boyd CJ, et al. Sources of prescription medication misuse among young adults in the United States: the role of educational status. J Clin Psychiatry. 2018;79:17m11958.
   PubMed Web of Science ®Google Scholar
• Young AM, Glover N, Havens JR. Nonmedical use of prescription medications among adolescents in the United States: a systematic review. J Adolesc Health. 2012;51:6–17.
   PubMed Web of Science ®Google Scholar
• Lo CC, Monge AN, Howell RJ, et al. The role of mental illness in alcohol abuse and prescription drug misuse: gender-specific analysis of college students. J Psychoactive Drugs. 2013;45:39–47.
   PubMed Web of Science ®Google Scholar
• Huang B, Dawson DA, Stinson FS, et al. Prevalence, correlates, and comorbidity of nonmedical prescription drug use and drug use disorders in the United States: results of the National epidemiologic survey on alcohol and related conditions. J Clin Psychiatry. 2006;67:1062–1073.
   PubMed Web of Science ®Google Scholar
• Fischer B, Lusted A, Roerecke M, et al. The prevalence of mental health and pain symptoms in general population samples reporting nonmedical use of prescription opioids: a systematic review and meta-analysis. J Pain. 2012;13:1029–1044.
   PubMed Web of Science ®Google Scholar
• Goldner EM, Lusted A, Roerecke M, et al. Prevalence of Axis-1 psychiatric (with focus on depression and anxiety) disorder and symptomatology among non-medical prescription opioid users in substance use treatment: systematic review and meta-analyses. Addict Behav. 2014;39:520–531.
   PubMed Web of Science ®Google Scholar
• Institute of Medicine (US) -IOM- Committee on Advancing Pain Research, Care, and Education. Relieving pain in America: a blueprint for transforming prevention, care, education, and research. Washington (DC): The National Academies Press; 2011.
   Google Scholar
• Miller LR, Cano A. Comorbid chronic pain and depression: who is at risk? J Pain. 2009;10:619–627.
   PubMed Web of Science ®Google Scholar
• Epstein SA, Kay G, Clauw D, et al. Psychiatric disorders in patients with fibromyalgia. A multicenter investigation. Psychosomatics. 1999;40:57–63.
   PubMed Web of Science ®Google Scholar
• Katona C, Peveler R, Dowrick C, et al. Pain symptoms in depression: definition and clinical significance. Clin Med. 2005;5:390–395.
   PubMed Web of Science ®Google Scholar
• Kroenke K, Wu J, Bair MJ, et al. Reciprocal relationship between pain and depression: a 12-month longitudinal analysis in primary care. J Pain. 2011;12:964–973.
   PubMed Web of Science ®Google Scholar
• Meerwijk EL, Ford JM, Weiss SJ. Brain regions associated with psychological pain: implications for a neural network and its relationship to physical pain. Brain Imaging Behav. 2013;7:1–14.
   PubMed Web of Science ®Google Scholar
• Han B, Compton WM, Jones CM, et al. Nonmedical prescription opioid use and use disorders among adults aged 18 through 64 years in the United States, 2003-2013. JAMA. 2015;314:1468–1478.
   PubMed Web of Science ®Google Scholar
• Substance Abuse and Mental Health Services Administration-SAMHSA. 2016 [cited 2018 Jul 20]. Available from: http://www.samhsa.gov/data/
   Google Scholar
• Center for Behavioral Health Statistics and Quality-CBHSQ. Behavioral health trends in the United States: results from the 2014 National survey on drug use and health (HHS Publication No. SMA 15-4927, NSDUH Series H-50); 2015. [cited 2018 Jul 23]. Available from: http://www.samhsa.gov/data/
   Google Scholar
• Kessler RC, Berglund P, Chiu WT, et al. The US National Comorbidity Survey Replication (NCS-R): design and field procedures. Int J Methods Psychiatr Res. 2004;13:69–92.
   PubMed Web of Science ®Google Scholar
• American Psychiatric Association-APA. Diagnostic and statistical manual of mental disorders. 4th ed. Washington (DC): American Psychiatric Association; 1994.
   Google Scholar
• Center for Behavioral Health Statistics and Quality-CBHSQ. 2014 National survey on drug use and health: methodological summary and definitions. Rockville (MD): Substance Abuse and Mental Health Services Administration; 2015.
   Google Scholar
• Harvard School of Medicine. Harvard School of Medicine Home page: National Comorbidity Survey (NCS), section Adolescent Supplement. [ cited 2018 Jul 23]. Available from: http://www.hcp.med.harvard.edu/ncs/
   Google Scholar
• Wu L-T, Ringwalt CL, Mannelli P, et al. Prescription pain reliever abuse and dependence among adolescents: a nationally representative study. J Am Acad Child Adolesc Psychiatry. 2008;47:1020–1029.
   PubMed Web of Science ®Google Scholar
• Greenland S. Interpretation and choice of effect measures in epidemiologic analyses. Am J Epidemiol. 1987;125:761–768.
   PubMed Web of Science ®Google Scholar
• Campbell UB, Gatto NM, Schwartz S. Distributional interaction: interpretational problems when using incidence odds ratios to assess interaction. Epidemiol Perspect Innov. 2005;2:1.
   PubMedGoogle Scholar
• Schepis TS, Hakes JK. Non-medical prescription use increases the risk for the onset and recurrence of psychopathology: results from the National epidemiological survey on alcohol and related conditions. Addiction. 2011;106:2146–2155.
   PubMed Web of Science ®Google Scholar
• Blanco C, Rafful C, Wall MM, et al. The latent structure and predictors of non-medical prescription drug use and prescription drug use disorders: a national study. Drug Alcohol Depend. 2013;133:473–479.
   PubMed Web of Science ®Google Scholar
• Fischer B, Murphy Y, Kurdyak P, et al. Depression - A major but neglected consequence contributing to the health toll from prescription opioids? Psychiatry Res. 2016;243:331–334.
   PubMed Web of Science ®Google Scholar
• Pjanic I, Messerli-Bürgy N, Bachmann MS, et al. Predictors of depressed mood 12 months after injury. Contribution of self-efficacy and social support. Disabil Rehabil. 2014;36:1258–1263.
   PubMed Web of Science ®Google Scholar
• Shuster J, McCormack J, Pillai Riddell R, et al. Understanding the psychosocial profile of women with fibromyalgia syndrome. Pain Res Manag. 2009;14:239–245.
   PubMed Web of Science ®Google Scholar
• Swinkels-Meewisse IEJ, Roelofs J, Oostendorp RAB, et al. Acute low back pain: pain-related fear and pain catastrophizing influence physical performance and perceived disability. Pain. 2006;120:36–43.
   PubMed Web of Science ®Google Scholar
• Dorner TE, Alexanderson K, Svedberg P, et al. Synergistic effect between back pain and common mental disorders and the risk of future disability pension: a nationwide study from Sweden. Psychol Med. 2016;46:425–436.
   PubMed Web of Science ®Google Scholar
• Stanos S, Brodsky M, Argoff C, et al. Rethinking chronic pain in a primary care setting. Postgrad Med. 2016;128:502–515.
   PubMed Web of Science ®Google Scholar
• Martins SS, Fenton MC, Keyes KM, et al. Mood and anxiety disorders and their association with non-medical prescription opioid use and prescription opioid-use disorder: longitudinal evidence from the National epidemiologic study on alcohol and related conditions. Psychol Med. 2012;42:1261–1272.
   PubMed Web of Science ®Google Scholar
• Grenald SA, Largent-Milnes TM, Vanderah TW. Animal models for opioid addiction drug discovery. Expert Opin Drug Discov. 2014;9:1345–1354.
   PubMed Web of Science ®Google Scholar
• Lutz P-E, Kieffer BL. Opioid receptors: distinct roles in mood disorders. Trends Neurosci. 2013;36:195–206.
   PubMed Web of Science ®Google Scholar
• Lipari RN, Williams M, Van Horn SL. Why do adults misuse prescription drugs? The CBHSQ report. Rockville (MD): Substance Abuse and Mental Health Services Administration; 2017.
   Google Scholar
• Hobden B, Carey M, Bryant J, et al. Clinician identification of elevated symptoms of depression among individuals seeking treatment for substance misuse. Drug Alcohol Depend. 2017;181:71–76.
   PubMed Web of Science ®Google Scholar
• National Pain Strategy Objectives & Updates. National Institutes of Health; 2016 [cited 2018 Jul 20]. Available from: https://iprcc.nih.gov/National-Pain-Strategy/Objectives-Updates
   Google Scholar
• Centers for Disease Control and Prevention-CDC. Annual Surveillance Report of Drug-Related Risks and Outcomes — United States. Surveillance Special Report 1. Centers for disease control and prevention, U.S. Department of health and human services; 2017. [cited 2018 Jul 23]. Available from: https://www.cdc.gov/drugoverdose/pdf/pubs/2017-cdc-drug-surveillance-report.pdf
   Google Scholar
• Volkow ND, Frieden TR, Hyde PS, et al. Medication-assisted therapies–tackling the opioid-overdose epidemic. N Engl J Med. 2014;370:2063–2066.
   PubMed Web of Science ®Google Scholar
• Carrà G, Clerici M. Dual diagnosis–policy and practice in Italy. Am J Addict. 2006;15:125–130.
   PubMed Web of Science ®Google Scholar
• McGovern MP, Lambert-Harris C, Gotham HJ, et al. Dual diagnosis capability in mental health and addiction treatment services: an assessment of programs across multiple state systems. Adm Policy Ment Health. 2014;41:205–214.
   PubMed Web of Science ®Google Scholar
• Graham K, Cheng J, Bernards S, et al. How much do mental health and substance use/addiction affect use of general medical services? Extent of use, reason for use, and associated costs. Can J Psychiatry. 2017;62:48–56.
   PubMed Web of Science ®Google Scholar
• Brunette MF, Asher D, Whitley R, et al. Implementation of integrated dual disorders treatment: a qualitative analysis of facilitators and barriers. Psychiatr Serv. 2008;59:989–995.
   PubMed Web of Science ®Google Scholar
• Carrà G, Crocamo C, Borrelli P, et al. Correlates of dependence and treatment for substance use among people with comorbid severe mental and substance use disorders: findings from the “Psychiatric and addictive dual disorder in Italy (PADDI)” Study. Compr Psychiatry. 2015;58:152–159.
   PubMed Web of Science ®Google Scholar
• Center for Disease and Control Prevention-CDC. Rx awareness. [ cited 2018 Jul 23]. Available from: https://www.cdc.gov/rxawareness/
   Google Scholar
• Center for Behavioral Health Statistics and Quality-CBHSQ. 2014 National survey on drug use and health: detailed tables. Rockville (MD): Substance Abuse and Mental Health Services Administration; 2015.
   Google Scholar
• Carrà G, Scioli R, Monti MC, et al. Severity profiles of substance-abusing patients in Italian community addiction facilities: influence of psychiatric concurrent disorders. Eur Addict Res. 2006;12:96–101.
   PubMed Web of Science ®Google Scholar